The ÎÛÎÛ²ÝÝ®ÊÓƵ Interdisciplinary Initiative in Infection and Immunity (MI4) is pleased to announce the launch of an emergency coronavirus research fund to support nimble and effective interventions and...
TORONTO, Feb. 4, 2021 /CNW/ - Diamond Therapeutics Inc. ("Diamond"), a leading psychedelic drug development company focused on low-dose therapies for mental health, has entered into an agreement...